Article
Seasonal malaria chemoprevention and the spread of Plasmodium falciparum quintuple-mutant parasites resistant to sulfadoxine-pyrimethamine: a modelling study.
The Lancet. Microbe - 1 Sept 2024
Masserey Thiery, Lee Tamsin, Kelly Sherrie L, Hastings Ian M, Penny Melissa A
Abstract excerpt
BACKGROUND: Seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine plus amodiaquine prevents millions of clinical malaria cases in children younger than 5 years in Africa's Sahel region. However, Plasmodium falciparum parasites partially resistant to sulfadoxine-pyrimethamine (with quintuple mutations) potentially threaten the protective effectiveness of SMC. We evaluated the spread of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
